Camberlogo1 (Camberlogo1)
Sildenafil Tablet, Film Coated
Product Images NDC 71335-1088
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 71335-1088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Camberlogo2 (Camberlogo2)
Sildenafilfigure7 (Sildenafilfigure7)
A vertical bar graph depicting the percentage of patients reporting improvement across four treatment groups: Placebo, Sildenafil Citrate Tablets 25 mg, 50 mg, and 100 mg. Improvement percentages increase from 24% with placebo up to 82% with 100 mg sildenafil citrate. Sample sizes for each group are indicated below the bars.*
Label (Lbl713351088)
Sildenafil Citrate 100 mg tablet label from Bryant Ranch Prepack, featuring a white round tablet description, comparison to Viagra 100 mg tablet by Hetero Labs Limited, and storage instructions at 20°-25°C (68°-77°F). The label includes an NDC number 71335-1088-1 and a barcode, with warnings to keep drugs out of reach of children.*
Sildenafilfigure1 (Sildenafilfigure1)
A line graph comparing the effects of Sildenafil 100 mg and placebo on systolic blood pressure (mmHg) over 24 hours post dose. The x-axis represents time in hours, and the y-axis represents change in systolic blood pressure, showing variations for both groups from pre-dose through 24 hours.*
Sildenafilfigure2 (Sildenafilfigure2)
A line graph displaying change in blood pressure over time for two groups: one treated with Placebo and the other with Sildenafil 100 mg. The x-axis represents time in hours, and the y-axis represents blood pressure change in mmHg. Data points show trends for both treatments during the evaluated time period.*
Sildenafilfigure3 (Sildenafilfigure3)
A line graph depicting change in a measured variable (possibly blood pressure) over time post-dose (in hours). Two data series are shown: one for Diclofenac + Placebo and another for Diclofenac + Sildenafil 50 mg, with time on the x-axis and change in the variable on the y-axis.*
Sildenafilfigure4 (Sildenafilfigure4)
A line graph comparing two treatment groups over an 8-hour time course. The vertical axis shows a parameter labeled in negative values (possibly measurement units), while the horizontal axis represents time after dosing in hours. Two lines represent 'Doxazosin + Sildenafil 100 mg' and 'Doxazosin + Placebo,' each with markers and error bars illustrating trend differences or similarities over time.*
Sildenafilfigure5 (Sildenafilfigure5)
A line graph showing plasma concentration (ng/mL) of a treatment labeled as Commercial Tablet over time post-dose in hours. The graph depicts a rapid increase in plasma concentration reaching a peak near 1 hour, followed by a gradual decline over a 24-hour period.*
Sildenafilfigure6a (Sildenafilfigure6a)
Bar chart displaying the percentage of patients at endpoint versus baseline score. The chart includes multiple bars for each baseline score category, distinguished by numerical labels from 0 to 5, showing comparative patient percentages across these categories.*
Sildenafilfigure6b (Sildenafilfigure6b)
A bar chart showing the percentage of patients at endpoint by baseline score. The x-axis represents baseline scores from 0 to 5, and the y-axis represents the percentage of patients. Multiple bars per baseline score correspond to categories labeled 00, 1, 2, 3, 4, and 5. The chart compares distributions across these categories at each baseline score.*
Sildenafilheterologo1 (Sildenafilheterologo1)
Sildenafilheterologo2 (Sildenafilheterologo2)
Sildenafilstructure (Sildenafilstructure)
Chemical structure of Sildenafil, shown with detailed molecular groups including a sulfonamide and piperazine ring, as well as an acidic salt form on the right side of the diagram.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
